RheumNow Live 2024

Description

+ Include: 42 videos, size: 35.05 GB

+ Target Audience: rheumatologists and clinical immunologists

+ Sample video: contact me for sample video

+ Information:

1. Overview

The RheumNow Live 2024 course provides a comprehensive clinical update on the diagnosis and management of complex rheumatic and autoimmune diseases. The program features expert-led sessions on the latest therapeutic advancements, clinical guidelines, and emerging biomarkers across core rheumatology domains, including SLE, rheumatoid arthritis, psoriatic disease, and spondyloarthritis.

Course Date: 2024

2. Learning Objectives

• Evaluate the biology of lupus flares and implement emerging biomarkers for the accurate diagnosis and treatment of SLE.

• Apply updated ACR, EULAR, and GRAPPA guidelines for the selection of systemic therapies in psoriatic disease and spondyloarthritis.

• Assess the clinical efficacy, safety concerns, and expanding applications of JAK inhibitors within the rheumatology treatment paradigm.

• Formulate proactive clinical strategies for the prevention and nutritional management of rheumatoid arthritis.

• Implement evidence-based approaches for managing ANCA-associated vasculitis, addressing pregnancy complexities, and mitigating malignancy risks in myositis.

3. Target Audience

Best for rheumatologists and clinical immunologists who want updates on SLE, rheumatoid arthritis, JAK inhibitors, and spondyloarthritis.

4. Topics

1. Adjourn

2. Biology and Rx of Lupus Flares

3. BONUS STEP

4. Choosing Systemic Therapies for Psoriatic Disease

5. CurrentFuture Biomarkers in SLE

6. Enthesitis in Spondyloarthritis

7. EULAR vs ACR vs GRAPPA Guidelines

8. Expanding Use of JAK Inhibitors in Dermatology

9. Future Therapy of Axial Spondyloarthritis

10. Gender Differences in PsA Outcomes Management

11. GPA Managment in 2024

12. JAK Faculty QA

13. JAK Inhibition in Spondyloarthritis

14. JAK Inhibitors in the Paradigm

15. Lessons from Cardio-Rheumatology Clinic

16. Mastering SLE

17. Nonradiographic Axial Spondyloarthritis

18. Nutrition in RA

19. Prevention of RA

20. Psoriatic Arthritis – Hot Topics

21. Psoriatic Faculty QA

22. RA Faculty Panel QA

23. Rethinking Pre-Clinical Disease in Lupus

24. Rheumatoid Arthritis Success in Rheumatoid Arthritis

25. Safety Concerns with JAK Inhibitors

26. SLE Faculty Panel QA

27. Spondyloarthritis Faculty Panel QA

28. Spondyloarthritis Spectrum

29. STEP Appreciative Rheumatology Building On The Positive

30. STEP Dead Words Eulogy

31. STEP Ethics in Rheumatology

32. STEP Immunosenescence in RA

33. STEP Lest we forget the flare

34. STEP Myositis Malignancy Risk Screening

35. STEP Myths Mistakes on ANCA-Associated Vasculitis

36. Treat to Target in Vasculitis

37. Vasculitis Faculty Panel QA

38. Vasculitis Mavens

39. Vasculitis Pregnancy

40. VIRTUAL SHOWCASE – Clinical Relevance of High Rheumatoid Factor in Patients With Rheumatoid Arthritis Non-CME

41. VIRTUAL SHOWCASE – DEFY Expectations Challenge Treatment Goals in Your Adult TNFi-IR Patients with Active Psoriatic A…

42. Welcome Introductions